News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
712
Sources here
21
Companies here
19
Search results Stored financial headlines

Active search

712 matching headlines

Ticker or company: IRIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for IRIDEX Corp (IRIX), indicating a current earnings forecast score of 8.00 and a "Buy" rating based on one analyst. It details future revenue and EPS expectations, with an anticipated next-quarter revenue of $12.98 million and an EPS …

IRIX main company
Sharemaestro market context Price below Trend Line 52 weeks -31.0% · Next-week setup negative 44.2% IRIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Enviri Corp (NVRI) Earnings Forecast: Future EPS & Revenue Growth Estimates

Enviri Corp (NVRI) has an earnings forecast score of 7.33, placing it 93rd out of 159 in its industry. Analysts have set an average price target of $21.00, with a consensus indicating a "Buy" trend. The company's expected revenue for the next quarter is …

NVRI main company
Sharemaestro market context Stored weekly price path 12 weeks +15.5% · Next-week setup positive 69.1% NVRI stored weekly price path from 29 May 2026 to 14 Aug 2026

Iridium Communications Inc (IRDM) News, Articles, Events & Latest Updates

This article provides a compilation of recent news and updates regarding Iridium Communications Inc. (IRDM). It covers various financial analyses, including potential growth catalysts, valuation concerns, and the impact of the Aireon deal and Rocket Lab acquisition on Iridium's revenue and outlook. The news …

IRDM main company
Sharemaestro market context Trend signal active 52 weeks +106.3% IRDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Investors Are Reacting To Sirius XM (SIRI) Boosting Guidance Amid Record-Low Churn And New Sports Pass

Sirius XM Holdings reported strong Q2 2026 results, boosting full-year revenue guidance to US$8.53 billion, driven by record-low churn and a return to subscriber growth. The company's strategy, including the new SiriusXM Sports Pass, aims to widen its market and improve subscriber retention. While …

SIRI main company
Sharemaestro market context Trend signal active 52 weeks +25.6% · Next-week setup negative 40.7% SIRI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Iridium’s SKYWAVE IoT Partnership Could Reshape Remote Connectivity For Iridium Communications (IRDM) Investors

Iridium Communications Inc. partnered with SKYWAVE to integrate Iridium's satellite network with SKYWAVE's IoT platform, aiming to enhance remote connectivity for heavy equipment manufacturers and other industrial sectors. This collaboration strengthens Iridium's IoT investment narrative by embedding its Short Burst Data into multi-network industrial …

IRDM main company
Sharemaestro market context Trend signal active 52 weeks +106.3% IRDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viridian Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Viridian Therapeutics Inc has released its earnings summary for the quarter that concluded on June 30. The report details the company's financial performance during this period, providing key insights into its operational results. This information is available through Refinitiv, with additional access offered via …

VRDN main company
Sharemaestro market context Price above Trend Line 52 weeks +14.9% VRDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viridian Therapeutics 2Q 2026: Revenue $284K, EPS $(1.05) — 10-Q Summary

Viridian Therapeutics reported its second-quarter 2026 results, showing early commercial revenue of $284K following FDA approval of Veligrotug (Lumvoa). The company experienced a wider net loss of $127.1M, reflecting its transition from an R&D to a commercial organization. Key highlights include the U.S. launch …

VRDN main company
Sharemaestro market context Price above Trend Line 52 weeks +14.9% VRDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says

RBC Capital Markets forecasts "minimal" revenue growth for Viridian Therapeutics (VRDN) in the second half of the year. The report, published by MT Newswires, indicates that a more meaningful inflection in revenue is expected after this period. Access to the full article requires a …

VRDN main company
Sharemaestro market context Price above Trend Line 52 weeks +14.9% VRDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sirius XM (NASDAQ: SIRI) files to sell 16,672 stock compensation shares

Sirius XM Holdings Inc. (SIRI) has filed a Form 144 notice to sell up to 16,672 shares of common stock, valued at $499,702.80, through Fidelity Brokerage Services LLC on the NASDAQ. The proposed sale date is August 6, 2026. These shares were acquired as …

SIRI main company
Sharemaestro market context Trend signal active 52 weeks +25.6% · Next-week setup negative 40.7% SIRI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sirius XM Holdings Inc (SIRI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Sirius XM Holdings Inc (SIRI), detailing its current price momentum score, support and resistance levels, and indicator and moving average signals. It notes that the stock is suitable for range-bound swing trading and includes FAQs on technical …

SIRI main company
Sharemaestro market context Trend signal active 52 weeks +25.6% · Next-week setup negative 40.7% SIRI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Iridium Communications (IRDM) details Rocket Lab acquisition process and upcoming S-4 proxy

Iridium Communications Inc. (IRDM) has outlined details regarding its proposed acquisition by Rocket Lab Corporation, emphasizing the process of filing a Registration Statement on Form S-4, which will include a proxy statement for Iridium stockholders. The acquisition, expected to close mid-2027, aims to create …

IRDM main company
Sharemaestro market context Trend signal active 52 weeks +106.3% IRDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Press Release: Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Viridian Therapeutics has released its second quarter 2026 financial results, alongside an update on recent business developments. This announcement provides insights into the company's financial performance and strategic progress during the quarter.

VRDN main company
Sharemaestro market context Price above Trend Line 52 weeks +14.9% VRDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending

OTTAWA, Ontario, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Assays are now pending from the first diamond drill holes completed as part of Viridian Metals Inc.'s (CSE: VRDN) (OTCQB: VIRMF) 2026 drill program at the Kraken project in Labrador. The initial assay submission includes the …

VRDN main company
Sharemaestro market context Price above Trend Line 52 weeks +14.9% VRDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dandurand, La Martiniquaise-Bardinet team up to buy Lamb’s rum

Dandurand and La Martiniquaise-Bardinet have agreed to acquire the Lamb's rum brand and "certain assets" from Corby Spirit and Wine. The deal was conducted via Maison des Futailles, which is majority owned by Canadian wine major Dandurand, and Glen Turner Company, part of the …

CSW-A main company CSW-B main company
Sharemaestro market context Trend signal active 52 weeks +14.2% CSW-A stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viridian Therapeutics reports Q2 2026 net loss of $127.1M, cash $981.5M after Lumvoa FDA approval

Viridian Therapeutics reported a Q2 2026 net loss of $127.1 million, with $981.5 million in cash, cash equivalents, and marketable securities. This report follows the FDA approval and U.S. commercial launch of Lumvoa for thyroid eye disease on June 26, 2026, and the company …

VRDN main company
Sharemaestro market context Price above Trend Line 52 weeks +14.9% VRDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Janus Henderson Group PLC Boosts Stock Holdings in Iridium Communications Inc $IRDM

Janus Henderson Group PLC increased its stake in Iridium Communications Inc. by 9.8% in the first quarter, now owning 306,684 shares valued at $8.5 million. Other institutional investors also adjusted their holdings, with Vanguard Group Inc. being the largest holder. Despite Iridium Communications reporting …

IRDM main company
Sharemaestro market context Trend signal active 52 weeks +106.3% IRDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sirius XM (SIRI) Is Down 5.8% After Raising 2026 Guidance And Shifting Its Strategic Mix

Sirius XM Holdings reported past second-quarter 2026 results with revenue of US$2,160 million and net income of US$239 million, and raised full-year 2026 revenue guidance to about US$8.53 billion after returning to positive net subscriber additions and record-low churn. Alongside stronger earnings, Sirius XM …

SIRI main company
Sharemaestro market context Trend signal active 52 weeks +25.6% · Next-week setup negative 40.7% SIRI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context